Earnings Feed
Start Free
Home/Filings/4/0000313143-14-000025
4//SEC Filing

HAEMONETICS CORP 4

Accession 0000313143-14-000025

$HAECIK 0000313143operating
View on SEC.govCompany Profile

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 1:54 PM ET

Size

15.2 KB

Accession

0000313143-14-000025

Insider Transaction Report

Form 4
Period: 2014-02-18
HAEMONETICS CORPHAE
HANLON SUSAN M
VP Finance
Transactions
  • Exercise/Conversion

    Common Stock

    2014-02-18$26.47/sh+3,690$97,674→ 20,595 total
  • Sale

    Common Stock

    2014-02-18$39.00/sh−3,690$143,910→ 16,905 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2014-02-18$39.00/sh−3,690$143,910→ 11,000 total
    Exercise: $26.47From: 2010-10-27Exp: 2016-10-27→ Common Stock (3,690 underlying)
Holdings

  • Non-Qualified Stock Option (right to buy)

    Exercise: $39.05From: 2013-10-24Exp: 2019-10-24→ Common Stock (16,882 underlying)
    16,882

  • Non-Qualified Stock Option (right to buy)

    Exercise: $27.50From: 2011-10-27Exp: 2017-10-27→ Common Stock (22,348 underlying)
    22,348

  • Non-Qualified Stock Option (right to buy)

    Exercise: $41.66From: 2014-10-23Exp: 2023-10-23→ Common Stock (18,456 underlying)
    18,456

  • Performance Shares

    Exercise: $0.00From: 2017-03-31Exp: 2017-12-31→ Common Stock (12,500 underlying)
    12,500

  • Non-Qualified Stock Option (right to buy)

    Exercise: $30.67From: 2012-10-25Exp: 2018-10-25→ Common Stock (20,726 underlying)
    20,726
Footnotes (3)
  • [F1]Pursuant to a 10b5-1 Plan.
  • [F2]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
  • [F3]Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).

Documents

1 file

Issuer

HAEMONETICS CORP

CIK 0000313143

→
Entity typeoperating
IncorporatedMA

Related Parties

1
  • filerCIK 0000313143

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 1:54 PM ET
Size
15.2 KB
View on SEC.gov